About This Interstitial Cystitis Bladder Pain Syndrome Study

This study is evaluating an investigational drug (a drug not approved for clinical use) for the potential treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) in women. The investigational drug will be compared with a placebo (a substance that looks exactly like the investigational drug used in a study, except it does not contain any active ingredients).

IC/BPS is painful and may get in the way of social activities, exercise, intimacy, and sleep.

We need clinical research to evaluate the safety and effectiveness of IC/BPS treatments for women.

If you qualify, you will receive 1 treatment of either the investigational drug or placebo.

This portion of the study will last up to 28 weeks and will consist of up to 9 visits to the study center, including 2 phone visits.

After at least 12 weeks following the first treatment, you may choose to receive a second treatment. This second treatment will be the investigational drug. Depending on if and when you request a second treatment, your total participation in the study will last between approximately 26 to 46 weeks with a total of up to 13 visits.

Participants will also be asked to complete an electronic study diary to keep track of urination and bladder pain.

Scroll to Top
Scroll to Top

Your choice regarding
cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website, you are giving us consent to collect cookies.